Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Infectious Disease
Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation
Wendy Y. Chenga Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USA
https://orcid.org/0000-0002-8281-2496
https://orcid.org/0000-0002-8281-2496, Robin K. Averyb Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, USAhttps://orcid.org/0000-0001-7692-3619
https://orcid.org/0000-0001-7692-3619, Philippe Thompson-Leduca Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USAhttps://orcid.org/0000-0001-9047-3941
https://orcid.org/0000-0001-9047-3941, , , Mei Sheng Duha Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USAhttps://orcid.org/0000-0001-5035-6687
https://orcid.org/0000-0001-5035-6687 & show allRelated Research Data
Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation
Source:
Taylor & Francis
Linking provided by
